Coeliac UK and Innovate UK have announced that the companies have £180k available for research and are inviting applications from UK businesses and researchers.
The collaboration is launching a second research call to industry and researchers to make improvements for people living with the autoimmune condition, coeliac disease.
Criteria for the projects must underpin and support Coeliac UK's top ten research priorities, for example improving diagnostics for coeliac disease, refractory coeliac disease and gluten related neurological conditions, developing tools for the long term management of coeliac disease and enhancing the quality of staple gluten free food.
Hilary Croft, CEO of Coeliac UK said that the company wants to “change the course of coeliac disease treatment through improved diagnostics, technology and food innovations that truly bridge the gap between people, health professionals and products. Research has the power to do this and by combining forces with Innovate UK and industry, our charity demonstrates its unwavering commitment to the UK’s growing gluten free community.
Earlier this year, three projects based in Birmingham, Newcastle and Edinburgh were awarded Coeliac UK, Innovate UK grants from the first joint research call - A new test to provide a less invasive way of diagnosing coeliac disease that may not rely on someone having to eat ongoing amounts of gluten, Development of three new plant proteins derived from crops, which are underused in the UK and Software innovation to help in the ongoing management of coeliac disease.
Coeliac UK announced that total project costs can range from £50k to £250k and researchers and businesses can jointly apply for a share of the funding up to the maximum £180K available.